Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
Basic Biosatistics for the Clinical Trialist | p. 3 |
Fundamental Concepts in Clinical Pharmacology | p. 37 |
Bioanalytical Methods in Clinical Drug Development | p. 63 |
Preclinical Models for Anticancer Drug Development | p. 89 |
Phase I Clinical Trials with Anticancer Agents | p. 117 |
Phase II Trials with Anticancer Agents | p. 141 |
Phase III Clinical Trials with Anticancer Agents | p. 163 |
Pharmacokinetic Studies in Early Anticancer Drug Development | p. 189 |
Pharmacodynamic Studies in Early Phase Drug Development | p. 215 |
Prediction of Antitumor Response | p. 257 |
Imaging Studies in Anticancer Drug Development | p. 275 |
Role of the US Food and Drug Administration in Cancer Drug Development | p. 305 |
Early Clinical Trials with Cytotoxic Agents | p. 335 |
Challenges and Saccesses in Developing Effective Anti-angiogenic Agents | p. 347 |
Targeted Therapeutics in Cancer Treatment | p. 403 |
Cancer Chemoprevention | p. 463 |
Combined Modality Therapy in Cancer Management | p. 483 |
Cancer Vaccines | p. 519 |
Optimising the Development of Antibodies as Treatment for Cancer | p. 535 |
Oligonucleotide Therapeutics | p. 569 |
Anticancer Drug Development in Pediatric Patients | p. 589 |
Clinical Trials in Special Populations | p. 603 |
NCI-Sponsored Clinical Trials | p. 631 |
Index | p. 659 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.